About Englewood Hospital and Medical Center

News

2013 Press Releases

Advanced Screening Tool Brings 3D Technology to Fight Against Breast Cancer

-Englewood Hospital’s New Imaging System May Help Detect Tumors Early-

(Englewood, NJ, June 6, 2013) – Englewood Hospital and Medical Center recently debuted a revolutionary new screening tool called tomosynthesis, an advanced mammography exam designed to improve detection of abnormalities in dense or nodular breast tissue, thanks to its groundbreaking 3D technology.

Hologic’s Selenia® Dimensions® Breast Tomosynthesis System is the latest addition to The Leslie Simon Breast Care and Cytodiagnosis Center’s full suite of diagnostic imaging services. The new system delivers incredibly sharp images of the breast in individual layers, allowing radiologists to view overlapping breast tissue separately.

“By enabling us to view the mammogram in multiple thin sections, tomosynthesis will ultimately improve visualization of possible abnormalities that may be hidden in dense breast tissue,” explained Mindy Goldfischer, MD, Chief of Breast Imaging at Englewood Hospital and Medical Center.

Dr. Goldfischer says 3D breast imaging is life-saving technology that will help to diagnose and treat breast cancer in its early stages, when the survival rate is highest.

“Englewood Hospital’s Breast Care Center already diagnoses a greater proportion of Stage 0 tumors than other local or national norms and the addition of tomosynthesis will only improve our lead in early detection,” added Dr. Goldfischer. “It also has the potential to offer fewer false positives and negatives, which certainly removes some of the anxiety from the exam process. This means our patients are less likely to get called back in for a second look and additional imaging.”

The system is designed to capture 2D and 3D images, allowing radiologists to perform either or both in a single compression. The imaging arm of the machine swings in an arc over the breast, instantly creating a series of 3D images. Very low x-ray energy is used during the screening examination, so radiation exposure remains safely below the American College of Radiology guidelines.

Breast cancer is the second leading cause of cancer death among women. Statistics indicate that one in eight women will develop breast cancer sometime in her life.

“Our decision to invest in this new technology is a decision to invest in the lives of our patients and their families,” said Dr. Goldfischer.

For information call 201-894-3000 ext. 6382 or visit www.englewoodhospital.com, click on the “Medical Services” tab and select “Breast Care Center.”

 
About Englewood Hospital and Medical Center
 
Englewood Hospital and Medical Center provides the highest level of compassionate, patient care and safety through a broad range of advanced clinical programs, treatments and diagnostic services. It is renowned for its bloodless medicine and surgery program, cardiac and vascular programs and its leadership in breast care, oncology and joint replacement services. Through its affiliation with the Mount Sinai School of Medicine and the Mount Sinai Consortium for Graduate Medical Education, this acute-care and community teaching hospital trains medical residents in many disciplines, including internal medicine, critical care medicine, surgery, pediatrics, podiatry, and pathology.   Additionally, many members of Englewood Hospital’s medical staff serve as faculty at Mount Sinai. Englewood Hospital has earned numerous accreditations from the Joint Commission and other organizations and is among the four percent of hospitals nationwide honored with the prestigious Magnet nursing award, a distinction that has been earned three times by its nursing staff.